Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Articles published by DiagnaMed Holdings Corp.

DiagnaMed Appoints John Karagiannidis as President & CEO; Fabio Chianelli Transitions to Director Role Strengthening Strategic Partnership with QIMC to Accelerate Natural Hydrogen Development in Ontario
From DiagnaMed Holdings Corp.
Via GlobeNewswire
Tickers CSE:DMED DGNMF
DiagnaMed Expands Clean Hydrogen Energy Extraction Capabilities to Demonstrate Proof of Concept of Proprietary Technology
From DiagnaMed Holdings Corp.
Via GlobeNewswire
Tickers CSE:DMED DGNMF
DiagnaMed Acquires Strategic Ontario Claims Adjacent to QIMC in Premier Temiscamingue Hydrogen District
From DiagnaMed Holdings Corp.
Via GlobeNewswire
Tickers CSE:DMED CSE:QIMC DGNMF QIMCF
DiagnaMed Advances Hydrogen Energy Technology Innovation
From DiagnaMed Holdings Corp.
Via GlobeNewswire
Tickers CSE:DMED DGNMF
DiagnaMed and TerraVent Announce Strategic Collaboration for Next-Generation Clean Hydrogen Production
From DiagnaMed Holdings Corp.
Via GlobeNewswire
Tickers CSE:DMED DGNMF
DiagnaMed Announces Resignation of Director and Grant of Stock Options
From DiagnaMed Holdings Corp.
Via GlobeNewswire
Tickers CSE:DMED DGNMF
DiagnaMed and QIMC to Advance Hydrogen Production Technology at the Ville Marie Clean Natural Renewable Hydrogen Project
From DiagnaMed Holdings Corp.
Via GlobeNewswire
Tickers CSE:DMED DGNMF
DiagnaMed Partners with Texas Tech University to Pioneer Hydrogen Innovation
From DiagnaMed Holdings Corp.
Via GlobeNewswire
Tickers CSE:DMED DGNMF
DiagnaMed and EIREX Collaborate to Develop and Commercialize Novel Modular Technology Producing Hydrogen from Water
From DiagnaMed Holdings Corp.
Via GlobeNewswire
Tickers CSE:DMED DGNMF
DiagnaMed Announces Stock Option Grants and Shares for Debt Settlement
From DiagnaMed Holdings Corp.
Via GlobeNewswire
Tickers CSE:DMED DGNMF
DiagnaMed Files U.S. Patent Application for Novel Methods of Producing Molecular Hydrogen
From DiagnaMed Holdings Corp.
Via GlobeNewswire
Tickers CSE:DMED DGNMF
DiagnaMed Advancing the Medical Potential of Hydrogen
From DiagnaMed Holdings Corp.
Via GlobeNewswire
Tickers CSE:DMED DGNMF
DiagnaMed Expands with Drug and Clinical Research AI Platform
From DiagnaMed Holdings Corp.
Via GlobeNewswire
Tickers CSE:DMED DGNMF
DiagnaMed Offering its Brain Health AI Platform for Investigating Weight Loss Drugs, such as Semaglutide (GLP-1), on Brain Function
From DiagnaMed Holdings Corp.
Via GlobeNewswire
Tickers CSE:DMED DGNMF
DiagnaMed Announces LIFE Offering of up to $650,000
From DiagnaMed Holdings Corp.
Via GlobeNewswire
Tickers CSE:DMED DGNMF
DiagnaMed’s BRAIN AGE® Brain Health AI Platform Targeting Multi-Billion Digital Brain Health Market
From DiagnaMed Holdings Corp.
Via GlobeNewswire
Tickers CSE:DMED DGNMF
DiagnaMed’s BRAIN AGE® Brain Health AI Platform Accomplishes Clinical Validation Milestone with Peer-Reviewed Paper
From DiagnaMed Holdings Corp.
Via GlobeNewswire
Tickers CSE:DMED DGNMF
DiagnaMed Announces Canadian Launch of BRAIN AGE® Brain Health AI
From DiagnaMed Holdings Corp.
Via GlobeNewswire
Tickers CSE:DMED DGNMF
DiagnaMed Adds New Launch Site of CERVAI™ Brain Health AI
From DiagnaMed Holdings Corp.
Via GlobeNewswire
Tickers CSE:DMED DGNMF
DiagnaMed Announces BRAIN AGE® Trademark Registration Approved by CIPO
From DiagnaMed Holdings Corp.
Via GlobeNewswire
Tickers CSE:DMED DGNMF
DiagnaMed Strengthening Intellectual Property Support for CERVAI™ Brain Health AI Solution
From DiagnaMed Holdings Corp.
Via GlobeNewswire
Tickers CSE:DMED DGNMF
DiagnaMed Accelerates Commercialization Initiatives of CERVAI™ Brain Health AI Solution
From DiagnaMed Holdings Corp.
Via GlobeNewswire
Tickers CSE:DMED DGNMF
DiagnaMed Announces Test Launch of CERVAI™ Brain Health in University Brain Health Center
From DiagnaMed Holdings Corp.
Via GlobeNewswire
Tickers CSE:DMED DGNMF
DiagnaMed Announces Pilot Launch of CERVAI™ Brain Health AI Solution
From DiagnaMed Holdings Corp.
Via GlobeNewswire
Tickers CSE:DMED DGNMF
DiagnaMed Accelerates Commercialization of CERVAI™ Brain Health AI Platform with Acceptance into the SOPHIE Program
From DiagnaMed Holdings Corp.
Via GlobeNewswire
Tickers CSE:DMED DGNMF
DiagnaMed Launches New Healthcare Provider Network Program for CERVAI™ Brain Health AI Platform in Canada and the USA
From DiagnaMed Holdings Corp.
Via GlobeNewswire
Tickers CSE:DMED DGNMF
DiagnaMed Provides Update for its Brain Health AI Platform, CERVAI™
From DiagnaMed Holdings Corp.
Via GlobeNewswire
Tickers CSE:DMED DGNMF
DiagnaMed Provides Update on CERVAI™, a Brain Health AI Platform Leveraging Generative AI
From DiagnaMed Holdings Corp.
Via GlobeNewswire
Tickers CSE:DMED DGNMF
DiagnaMed Launches PalGPT.ai, a Generative AI Brain Health Solution
From DiagnaMed Holdings Corp.
Via GlobeNewswire
Tickers CSE:DMED DGNMF
DiagnaMed Announces DTC Eligibility of Its Common Shares in the United States
From DiagnaMed Holdings Corp.
Via GlobeNewswire
Tickers CSE:DMED DGNMF
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.